Evidence map›Paper›PMID 28108781›Full record

ArticleEuropean journal of clinical pharmacology2017

Potentially inappropriate medications: predictor for mortality in a cohort of community-dwelling older adults.

Mariana Martins Gonzaga do Nascimento, Juliana Vaz de Melo Mambrini, Maria Fernanda Lima-Costa, Josélia Oliveira Araújo Firmo, Sérgio William Viana Peixoto, Antônio Ignácio de Loyola Filho

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of clinical pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Hypertension and Drug Adherence in the Elderly.Frontiers in cardiovascular medicine · 2020
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mariana Martins Gonzaga do NascimentoCenter for Studies on Aging and Public Health (NESPE), René Rachou Research Center (CPqRR), Oswaldo Cruz Foundation (FIOCRUZ), Belo Horizonte, Brazil. marianamgn@yahoo.com.br.
Juliana Vaz de Melo MambriniCenter for Studies on Aging and Public Health (NESPE), René Rachou Research Center (CPqRR), Oswaldo Cruz Foundation (FIOCRUZ), Belo Horizonte, Brazil.
Maria Fernanda Lima-CostaCenter for Studies on Aging and Public Health (NESPE), René Rachou Research Center (CPqRR), Oswaldo Cruz Foundation (FIOCRUZ), Belo Horizonte, Brazil.
Josélia Oliveira Araújo FirmoCenter for Studies on Aging and Public Health (NESPE), René Rachou Research Center (CPqRR), Oswaldo Cruz Foundation (FIOCRUZ), Belo Horizonte, Brazil.
Sérgio William Viana PeixotoCenter for Studies on Aging and Public Health (NESPE), René Rachou Research Center (CPqRR), Oswaldo Cruz Foundation (FIOCRUZ), Belo Horizonte, Brazil.
Antônio Ignácio de Loyola FilhoCenter for Studies on Aging and Public Health (NESPE), René Rachou Research Center (CPqRR), Oswaldo Cruz Foundation (FIOCRUZ), Belo Horizonte, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe objective of this study was to investigate whether the potentially inappropriate medication (PIM) use is a predictor for mortality in a community-based population of older adults.

methodsA cohort study was performed between January 1, 1997, and December 31, 2011, based on data from a representative sample of the population aged 60 years or older living in Bambuí, Brazil. Univariate and multivariate analyses of the association between the variable of interest (use of PIM or pharmacological groups of PIM) and mortality were based on the extended Cox model for proportional hazards. The extended model was adopted to include the measurement of the exposure of interest throughout the follow-up period and not only at baseline. Adjustment variables included sociodemographic characteristics, health status, and use of health care services and medications. A level of significance of 5% was adopted for all analyses.

resultsThe prevalence of PIM use was 56.0% (95%CI 53.4-58.6). After multiple adjustments, the risk of death among users of at least one PIM was 44% higher (HR = 1.44; 95%CI 1.21 to 1.71) than among those who did not use any PIM. Among the PIM groups analyzed, antipsychotics were the most strongly associated with mortality (HR = 2.33; 95%CI 1.72 to 3.17).

conclusionsThe study revealed a high prevalence of PIM use among the community-based aged population. It also identified PIM use as a predictor for mortality in this group of individuals. This indicates the need for selection of safer drug therapy alternatives in this patient group.

Indexed as

Potentially Inappropriate Medication ListAgedBrazilCohort StudiesFemaleHumansMaleMiddle AgedAgedBeers criteriaCohort studiesInappropriate prescribingMortalityPotentially inappropriate medication

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.